Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Topically used as a 0.2% cream or ointment for the treatment of wounds, ulcers, skin infections and burns.
At latest update relevant published data on its excretion into breast milk were not found.
It is not absorbed in significant amounts into the systemic circulation, even when applied on burned surfaces (AEMPS 2007).
The small dose used and low plasma uptake of most topical dermatological preparations make it unlikely that significant amounts would pass into breastmilk.
Do not apply on the breast to prevent the infant from taking it; if necessary, do it after a feeding and clean it up thoroughly with water before the next one. It is toxic when taken by mouth, may cause contact dermatitis and hemolysis in cases of glucose-6-phosphate dehydrogenase deficiency (AEMPS 2007).